Tenaya Therapeutics Inc (TNYA) — Cash Flow-to-Debt Ratio
Tenaya Therapeutics Inc (TNYA) has a Cash Flow-to-Debt Ratio of -0.71x as of September 2025, meaning its operating cash flow of $-15.60 Million could theoretically repay -1% of its total liabilities ($22.11 Million) in one year. See Tenaya Therapeutics Inc current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Tenaya Therapeutics Inc Cash Flow-to-Debt Ratio (2019–2024)
Historical debt coverage capacity for Tenaya Therapeutics Inc across 6 annual periods. Also explore Tenaya Therapeutics Inc (TNYA) equity growth momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Tenaya Therapeutics Inc (2019–2024)
Year-by-year debt coverage analysis for Tenaya Therapeutics Inc. For market capitalisation and broader financial context, see TNYA market cap.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -3.34x | $-90.50 Million | $27.09 Million | ▼ -1.8% |
| 2023 | -3.28x | $-102.07 Million | $31.09 Million | ▼ -11.8% |
| 2022 | -2.94x | $-104.42 Million | $35.57 Million | ▼ -84.0% |
| 2021 | -1.60x | $-60.81 Million | $38.12 Million | ▲ +60.7% |
| 2020 | -4.06x | $-35.45 Million | $8.72 Million | ▼ -1278.6% |
| 2019 | -0.29x | $-24.10 Million | $81.74 Million | — |